Princeton-based Sun Pharmaceutical Industries Limited on Thursday said it appointed Jeremy Allen as vice president, Corporate Affairs for North America.
In this newly created leadership role, Allen will spearhead Sun Pharma’s entire corporate affairs strategy across the United States and Canada, encompassing Government Affairs, Public Policy, Advocacy and Communications.
Richard Ascroft, Sun Pharma CEO, North America, expressed enthusiasm for the addition, stating, “With his expertise and strategic vision, Jeremy will serve an integral role in the continued growth of our business. Jeremy and his team will strengthen our engagement with stakeholders, shape policy environments, and ensure our voice reflects the values and priorities of the people who rely on our Innovative Medicines, Generics and Consumer Healthcare products,” he said.
Allen is a seasoned health care leader with over 25 years of industry experience, specializing in developing and leading campaign-style policy initiatives. He joins Sun Pharma from Spark Therapeutics, where he led U.S. government affairs and pricing & reimbursement functions. His prior experience includes leading the federal lobbying team at AHIP (formerly known as America’s Health Insurance Plans) and holding government affairs roles at Vertex Pharmaceuticals and Johnson & Johnson.
“I’m honored to join Sun Pharma at such a pivotal time in its growth journey,” Allen said. “I look forward to helping shape and share the story of Sun Pharma’s commitment to improving patient lives through accessible, high-quality medicines, especially as the company launches new Innovative Medicines that address unmet patient needs and Generics that play a vital role in lowering costs for the healthcare system.”
Allen began his career in government, working both on Capitol Hill and at the Centers for Disease Control and Prevention. The appointment underscores Sun Pharma’s commitment to external engagement as it continues to expand its footprint and Innovative Medicines portfolio in North America.
